首页> 中文期刊> 《中国临床保健杂志》 >阿托伐他汀对老年缺血性脑卒中患者氧化低密度脂蛋白和超氧化物歧化酶的影响

阿托伐他汀对老年缺血性脑卒中患者氧化低密度脂蛋白和超氧化物歧化酶的影响

         

摘要

Objective To observe the effect of alorvaslalin on oxidalive slress and Lipid peroxidalion in senile palienls with ischemic slroke. Methods 62 palienls were divided in conlrol group < n =30) and experimental group (n =32) . Palienls in conlrol group were given rouline treatment, while palienls in experimental group were given alorvaslalin besides rouline treatment. Plasma levels of ox-LDL and SOD were measured by ELISA method, ox-LDL and SOD were measured in two groups before and after treatment. Results After 10 ~ 14 days therapy, serum ox-LDL and SOD in experimental group were not change more. But ox-LDL levels in the conlrol group was higher than thai of admission ( P < 0. 01) and SOD level was lower than that of admission ( P < 0. 01 ) . Conclusion Alorvaslalin may play an important role in the treatment and impromenl of prognosis of acute cerebral infarction from anlioxidanl.%目的 分析阿托伐他汀在治疗老年急性缺血性脑卒中的抗氧化应激作用.方法 将62例急性脑梗死患者随机分为对照组(30例)和研究组(32例),对照组给予常规药物治疗;研究组在常规药物治疗的基础上加用阿托伐他汀治疗.用ELISA法检测患者氧化低密度脂蛋白(ox-LDL)水平和超氧化物歧化酶(SOD)浓度,比较两组患者治疗前后ox-LDL和SOD水平的变化情况.结果 治疗10~14 d后研究组ox-LDL和SOD水平较入院时无明显变化,而对照组ox-LDL的水平较入院时升高[(48.46±9.47)×10-5mmol/L比(55.54±8.55)×10-5mmol/L,P<0.01],SOD水平较入院时降低[(20.52±6.66)u/ml比(17.99±5.89)u/ml,P<0.01].两组治疗后ox-LDL、T-SOD比较,均P<0.05.结论 阿托伐他汀从抗氧化应激的角度,可能对急性脑梗死的治疗及预后起重要作用.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号